期刊文献+

前列腺癌腹膜后转移合并下腔静脉瘤栓1例并文献复习

Retroperitoneal metastasis of prostate cancer with inferior vena cava thrombola:case report and literature review
原文传递
导出
摘要 目的探讨前列腺癌(PCa)腹膜后转移合并下腔静脉瘤栓临床表现及诊治,并行文献复习。方法报道1例PCa腹膜后转移合并下腔静脉瘤栓患者,表现为下腹部钝痛,伴下腹部、阴茎、阴囊、双下肢水肿,CTU及MRI提示腹膜后肿瘤,下腔静脉瘤栓,PCa。以PCa收治,超声引导下腹膜后穿刺提示:PCa腹膜后转移。结果根据病理学特点及免疫组化诊断为PCa腹膜后转移,给予亮丙瑞林联合恩扎卢胺药物治疗,目前患者下腹部及下肢水肿完全消失,下腔静脉再通。结论PCa转移最常见于骨和淋巴结,腹膜后转移合并下腔静脉瘤栓临床罕见,在老年患者PSA异常时应考虑到PCa转移的可能,ADT联合恩扎卢胺治疗效果良好。 Objective To investigate the clinical manifestations,diagnosis and treatment of retroperitoneal metastasis of prostate cancer(PCa)complicated with inferior vena cava tumor thrombolus.Methods A case of retroperitoneal metastasis of PCa with inferior vena cava tumor thrombus was reported.The patient presented with dull pain in the lower abdomen accompanied by edema in the lower abdomen,penis,scrotum and lower limbs.CTU and MRI suggested retroperitoneal tumor,inferior vena cava tumor thrombus and PCa.The patient was admitted with PCa and ultrasound guided retroperitoneal puncture suggested retroperitoneal metastasis of PCa.Results According to pathological features and immunohistochemistry,the patient was diagnosed as retroperitoneal metastasis of PCa.He was administrated with lepraline combined with endzalumide,and at present,the edema of lower abdomen and lower limbs was completely cured,and the inferior vena cava was recanalized.Conclusion Bone and lymph nodes are the most common metastasis site of PCa.Retroperitoneal metastasis combined with inferior vena cava tumor thrombus is rare in clinic.The possibility of PCa metastasis should be considered when PSA is abnormal in elderly patients.ADT combined with enzalumide has a good therapeutic effect.
作者 张彪 侯倩 罗创 汉大黎 杨树军 尚攀峰 Zhang Biao;Hou Qian;Luo Chuang;Han Dali;Yang Shujun;Shang Panfeng(Department of Urology,The Second Hospital of Lanzhou University,Lanzhou 730030,Gansu,China)
出处 《中国男科学杂志》 CAS CSCD 2023年第1期94-98,共5页 Chinese Journal of Andrology
基金 甘肃省重点研发计划项目(20YF8FA081) 萃英科技创新(CY2021-MS-B16)。
关键词 前列腺肿瘤 腹膜后转移瘤 下腔静脉瘤栓 亮丙瑞林 恩扎卢胺 prostatic neoplasms retroperitoneal metastatic neoplasms inferior vena cava thrombolysis Leuprolide Enzalumide
  • 相关文献

参考文献4

二级参考文献36

  • 1那彦群,孙颖浩,徐勇,等.前列腺癌诊断治疗指南[M]//那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南:2014版.北京:人民卫生出版社,2013:61-89.
  • 2Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941 [ J]. J Urol,2002 ,167 :948-951, 952. DOI: 10. 1016/S0022-5347 (02) 80307-X.
  • 3Oefelein MG, Feng A, Scolieri MJ, et al. Reassessment of the definition of castrate levels of testosterone : implications for clinical decision making [ J ]. Urology, 2000,56 : 1021-1024. DOI: 10. 1016/S0090 -4295 ( 00 ) 00793 -7.
  • 4Morote J, Planas J, Salvador C, et al. Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy [ J ]. BJU Int, 2009,103 : 332-335, 335. DOI: 10. 1111/j. 1464-410X.2008.08062. x.
  • 5Pickles T, Hamm J, Morris WJ, et al. Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter? [J]. BJU Int,2012, 110: E500-E507. DOI : 10.1111/j. 1464-410X. 2012.11190. x.
  • 6Mohler JL, Armstrong AJ, Bahnson RR, et al. NCCN guideline for prostate cancer, Version 2. 20161 EB/OL 1. 2016 [ Version 2. 2016].
  • 7Gillessen S, Omlin A, Attard G, et al. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 [J]. Ann Oncol, 2015, 26 : 1589-1604. DOI: 10. 1093/annonc/ mdv257.
  • 8Leonard GG. Effective testosterone suppression for prostate cancer: is there a best castration therapy? [J]. Rev Urol. 2009, 11 : 52-60.
  • 9Klotz L, Boccon-Gibod L, Shore ND, et al. The efficacy and safety of degarelix : a 12-month, comparative, randomized, open- label, parallel-group phase Ⅲ study in patients with prostate cancer[J]. BJU Int,2008,102:1531-1538. DOI: 10. 1111/j.1464-410X. 2008. 08183. x.
  • 10Seidenfeld J, Samson D J, Hasselblad V, et al. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis [J]. Ann Intern Meal,2000, 132: 566-577. DOI: 10. 7326/0003-4819-132-7-200004040- 00009.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部